Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

NCT02948075

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Federal State budget Scientific Agency "Russian Oncological Research Center n.a. N.N. Blokhin" Moscow, Russia
  • Medical Radiological Scientific Center n.a. A.F. Tsyb - branch of Federal State Budget Agency "Public Medical Scientific Radiology Center" of Ministry of Health of Russian Federation Obninsk, Russia
  • State Budget Agency of Stavropol Territory Healthcare Pyatigorsk Oncologic Dispensary Pyatigorsk, Russia
  • State Budget Agency of Healthcare "Leningradsky Regional Oncologic Dispensary" Saint Petersburg, Russia
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

NCT02146313

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations
  • Florida Cancer Specialists - Sarasota (North Catttlemen Rd) Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
  • Hackensack Univ Med Ctr Hackensack, New Jersey, United States
View Trial Details
Completed

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

NCT01113957

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Site Reference ID/Investigator# 25028 Duarte, California, United States
  • Site Reference ID/Investigator# 25024 Encino, California, United States
  • Site Reference ID/Investigator# 25034 Los Angeles, California, United States
  • Site Reference ID/Investigator# 25037 Newport Beach, California, United States
View all 32 locations
View Trial Details

Related conditions